{{Rsnum
|rsid=2270993
|Gene=PTPRJ
|Chromosome=11
|position=48123614
|Orientation=minus
|GMAF=0.1524
|Gene_s=PTPRJ
|Assembly=GRCh38
|GenomeBuild=38.1
|dbSNPBuild=141
|geno1=(C;C)
|geno2=(C;T)
|geno3=(T;T)
}}{{ population diversity
| geno1=(C;C)
| geno2=(C;T)
| geno3=(T;T)
| CEU | 78.5 | 21.5 | 0.0
| HCB | 77.8 | 20.0 | 2.2
| JPT | 63.6 | 36.4 | 0.0
| YRI | 60.3 | 28.6 | 11.1
| ASW | 0.0 | 0.0 | 0.0
| CHB | 77.8 | 20.0 | 2.2
| CHD | 0.0 | 0.0 | 0.0
| GIH | 0.0 | 0.0 | 0.0
| LWK | 0.0 | 0.0 | 0.0
| MEX | 0.0 | 0.0 | 0.0
| MKK | 0.0 | 0.0 | 0.0
| TSI | 0.0 | 0.0 | 0.0
| HapMapRevision=28
}}{{PMID Auto
|PMID=23341091
|Title=High-resolution loss of heterozygosity screening implicates PTPRJ as a potential tumor suppressor gene that affects susceptibility to non-hodgkin's lymphoma
}}

{{on chip | HumanOmni1Quad}}